Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2002

View Archived Issues

Epicyte partners with aaiPharma to develop topical monoclonal antibody

MalariVax phase I commences at U.S. and U.K. sites

Discovery of back-up HNE inhibitors detailed by GSK

E-selectin vaccine prevents stroke in rat model

Roche designs neuroprotective agents with reduced side effect liability

Sustained beneficial effects reported for tadalafil in men with ED

Research findings support use of KRP-197 for overactive bladder

Micrologix acquires antiviral product and technology portfolio

Incenta presents new cruzipain inhibitors for use in Chagas' disease

AWD-12-281 compares favorably with other PDE4 inhibitors in terms of safety margin

Novel IL-8 antagonists and their use in psoriasis, arthritis, etc.

Merck and Isis researchers identify new HCV NS5B polymerase inhibitors

New alpha4beta1/alpha4beta7 integrin antagonists identified at Almirall Prodesfarma

Coagulation factor inhibitors covered by Merck patent

Lipoxin A4 produced in human bronchial epithelium, exerts antiinflammatory effects

Phase III Tarceva trial in NSCLC completes enrollment

Pharmexa reacquires AutoVac(TM) TNF-alpha pharmaccine

European approval for Fosrenol delayed

SuperGen's decitabine awarded orphan drug status for sickle cell anemia

Tularik advances T-487 into phase I trials

Xigris evaluated in severe sepsis patients at low risk of death

Provigil improves ADHD symptoms in children

Therion licenses rights to ICAM-1 from Boehringer Ingelheim

Debiopharm and Biolex form recombinant human therapeutic protein collaboration

Dyax schedules second phase II trial of DX-88 in hereditary angioedema

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...